NCT07564427 Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement
| NCT ID | NCT07564427 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Total Hip Arthroplasty (THA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-28 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-28 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to verify whether high-intensity pulsed electromagnetic fields (HI-PEMF) can be effectively applied to postoperative total hip arthroplasty patients. Using pain and function as the primary assessment indicators, the study explores the effects of HI-PEMF on postoperative total hip arthroplasty to confirm its effectiveness in relieving pain and improving daily living functions. Simultaneously, it combines physical therapy with exercise training to simulate a clinical environment, comprehensively understanding the feasibility of future clinical applications of magnetic field therapy. It is hoped that by exploring the potential benefits of magnetic field intervention in improving the postoperative condition of these high-needs patients, new clinical evidence can be provided for postoperative management.
Eligibility Criteria
Inclusion Criteria: A. Age 18 years or older. B. Patients who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis. C. Patients who, after postoperative evaluation by their surgeon, are advised to bear full weight within their tolerance. Exclusion Criteria: A. Patients who have not undergone primary hip arthroplasty. B. Patients who are advised by their doctor to maintain non-weight-bearing or partial weight-bearing on the affected or unaffected side. C. History of neurological deficits (e.g., sensory abnormalities, stroke, spinal cord injury, Parkinson's disease, multiple sclerosis). D. Mini-Mental State Examination (MMSE) \< 24 (mild cognitive impairment). E. Berger's Balance Scale (BBS) \< 40 (higher risk of falls). F. Sensory abnormalities. G. Before or after this exercise training, if pain in other areas (e.g., degenerative pain in the knee or spine) prevents movement, or if the hip joint still experiences pain on a Visual Analogue Scale (VAS) score of 4 or higher even after taking pain medication. H. Known malignancy. I. Schizophrenia, bipolar disorder, or substance addiction (e.g., alcohol, drug). J. Pregnant woman. K. Individuals with implanted stents, pacemakers, or those requiring treatment for arrhythmia. L. Wearing a hearing aid.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07564427 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Total Hip Arthroplasty (THA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07564427 currently recruiting?
Yes, NCT07564427 is actively recruiting participants. Contact the research team at nick0223.chang@gmail.com for enrollment information.
Where is the NCT07564427 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07564427 clinical trial?
NCT07564427 is sponsored by National Taiwan University Hospital. The trial plans to enroll 40 participants.